Azimut Holding S.p.A. (BIT:AZM)

Ligand Pharmaceuticals Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	-	394.8	464.57	298.14	180.04	279.46
Short-Term Investments	-	0.47	5.91	0.7	0.29	0.54
Cash & Short-Term Investments	610.17	395.28	470.48	298.84	180.33	280
Cash Growth	-15.05%	-15.98%	57.44%	65.71%	-35.59%	14.22%
Accounts Receivable	-	298.22	241.58	164.5	466.18	205.89
Other Receivables	-	252.88	237.12	326.63	295.07	296.34
Receivables	-	570.19	499.41	510.51	803.69	519.81
Prepaid Expenses	-	-	-	146.02	119.28	80.4
Total Current Assets	-	965.47	969.88	955.37	1,103	880.21
Property, Plant & Equipment	-	29.47	45.88	48.56	52.04	48.43
Long-Term Investments	-	8,455	7,854	7,604	7,980	6,876
Goodwill	-	508	749.83	743.67	648.24	550.11
Other Intangible Assets	-	73.06	142.91	134.58	118.79	106.58
Long-Term Deferred Tax Assets	-	17.98	19.41	22.89	20.31	12.18
Long-Term Deferred Charges	-	178.04	171.04	-	-	-
Other Long-Term Assets	-	5.92	5.63	5.28	-	-
Total Assets	-	10,233	9,958	9,515	9,922	8,474
Accounts Payable	-	45.96	78.99	82.8	77.49	66.03
Accrued Expenses	-	129.33	123.49	123.86	135.05	104.82
Current Portion of Long-Term Debt	-	-	496.98	0.42	-	5.77
Current Income Taxes Payable	-	60.1	142.73	120.12	71.83	10.29
Total Current Liabilities	-	235.39	842.19	327.2	284.37	186.91
Long-Term Debt	-	0.15	0.22	497.78	853.03	901.17
Long-Term Leases	-	27.67	40.24	41.46	44.98	41.56
Long-Term Unearned Revenue	-	0.98	0.79	1.14	1.7	1.25
Long-Term Deferred Tax Liabilities	-	69.27	76.94	75	69.89	61.74
Other Long-Term Liabilities	-	7,952	7,389	7,100	7,433	6,395
Total Liabilities	-	8,285	8,349	8,042	8,687	7,587
Common Stock	-	32.32	32.32	32.32	32.32	32.32
Additional Paid-In Capital	-	173.99	173.99	173.99	173.99	173.99
Retained Earnings	-	1,795	1,482	412.93	611.92	388.16
Treasury Stock	-	-7.51	-55.07	-56.49	-40.83	-68.29
Comprehensive Income & Other	-	-70.57	-82.86	854.68	405.25	339.71
Total Common Equity	2,020	1,923	1,551	1,417	1,183	865.89
Minority Interest	-	24.85	58.74	54.8	52.94	20.17
Shareholders' Equity	2,031	1,948	1,609	1,472	1,236	886.06
Total Liabilities & Equity	-	10,233	9,958	9,515	9,922	8,474
Total Debt	27.14	27.83	537.45	539.67	898.01	948.5
Net Cash (Debt)	583.03	367.45	-66.97	-240.83	-717.67	-668.5
Net Cash Per Share	4.11	2.62	-0.48	-1.73	-5.16	-4.82
Filing Date Shares Outstanding	141.89	141.6	138.45	138.39	139.61	138.24
Total Common Shares Outstanding	141.89	141.6	138.45	138.39	139.61	138.24
Working Capital	-	730.08	127.69	628.17	818.93	693.3
Book Value Per Share	14.24	13.58	11.20	10.24	8.47	6.26
Tangible Book Value	1,410	1,342	657.82	539.18	415.61	209.19
Tangible Book Value Per Share	9.94	9.48	4.75	3.90	2.98	1.51
Buildings	-	99.71	99.3	92.54	78.97	66.96
Machinery	-	16.04	15.01	14.79	13.4	11.77

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.